DK136526B - Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf.

Info

Publication number
DK136526B
DK136526B DK632070AA DK632070A DK136526B DK 136526 B DK136526 B DK 136526B DK 632070A A DK632070A A DK 632070AA DK 632070 A DK632070 A DK 632070A DK 136526 B DK136526 B DK 136526B
Authority
DK
Denmark
Prior art keywords
naphthylalkylamines
substituted
preparation
acid addition
addition salts
Prior art date
Application number
DK632070AA
Other languages
Danish (da)
English (en)
Other versions
DK136526C (ru
Inventor
Kurt Schromm
Anton Mentrup
Ernst-Otto Renth
Werner Traunecker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK136526B publication Critical patent/DK136526B/da
Application granted granted Critical
Publication of DK136526C publication Critical patent/DK136526C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Amplifiers (AREA)
DK632070AA 1969-12-12 1970-12-11 Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf. DK136526B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1962497A DE1962497C3 (de) 1969-12-12 1969-12-12 Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
DK136526B true DK136526B (da) 1977-10-24
DK136526C DK136526C (ru) 1978-03-28

Family

ID=5753745

Family Applications (1)

Application Number Title Priority Date Filing Date
DK632070AA DK136526B (da) 1969-12-12 1970-12-11 Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf.

Country Status (25)

Country Link
US (1) US3966814A (ru)
JP (3) JPS5116420B1 (ru)
KR (2) KR780000007B1 (ru)
AR (2) AR194205A1 (ru)
AT (3) AT302284B (ru)
BE (1) BE760252A (ru)
BG (1) BG17956A3 (ru)
CH (1) CH556322A (ru)
CS (3) CS151062B2 (ru)
DE (1) DE1962497C3 (ru)
DK (1) DK136526B (ru)
ES (3) ES386345A1 (ru)
FI (1) FI53301C (ru)
FR (1) FR2081347B1 (ru)
GB (1) GB1330188A (ru)
HU (1) HU162736B (ru)
IE (1) IE34807B1 (ru)
IL (1) IL35840A (ru)
NL (1) NL169583C (ru)
NO (1) NO131126C (ru)
PL (3) PL84355B1 (ru)
RO (3) RO61132A (ru)
SE (1) SE378101B (ru)
SU (2) SU417936A3 (ru)
YU (3) YU35753B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2187319B1 (ru) * 1972-06-09 1975-06-20 Bottu Exploit Labo
GB1535435A (en) * 1975-12-11 1978-12-13 Tanabe Seiyaku Co Benzyl alcohol derivatives
JPS53149940A (en) * 1977-06-02 1978-12-27 Tanabe Seiyaku Co Ltd Novel benzyl alcohol derivatives and their preparation
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
PT88988B (pt) * 1987-11-13 1993-02-26 Glaxo Group Ltd Processo para a preparacao de derivados da fenetanolamina
US5194450A (en) * 1988-04-20 1993-03-16 Burroughs Wellcome Co. Anti-hypertensive sulfonanilides
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides
ATE359993T1 (de) * 1997-08-05 2007-05-15 Pola Chem Ind Inc Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
TW200605867A (en) 2004-03-17 2006-02-16 Novartis Ag Use of organic compounds
AU2013202127B2 (en) * 2006-08-10 2014-06-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
CA2660707C (en) 2006-08-10 2014-07-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
AU2011224241B2 (en) 2010-03-10 2014-05-08 Sri International The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
JP6208031B2 (ja) * 2014-01-30 2017-10-04 東芝ライフスタイル株式会社 ブラシレスモータおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894396C (de) * 1944-05-21 1953-10-26 Troponwerke Dinklage & Co Verfahren zur Herstellung von 1-(o-, m- oder p-Oxyphenyl)-1-oxy-2-aralkylamino-aethanen
US3135797A (en) * 1958-04-15 1964-06-02 Colgate Palmolive Co Aromatic amino antispasmodic compounds
US3139441A (en) * 1960-02-16 1964-06-30 Colgate Palmolive Co Alpha (3, 4 dihidroxy phenyl)-beta-(nu-3, 14'-methylenedioxy-phenyl)-alkylamino ethanols
NL125650C (ru) * 1962-11-30 1900-01-01
GB1059968A (en) * 1964-01-20 1967-02-22 Ici Ltd Naphthalene derivatives
NL6401871A (ru) * 1964-02-27 1965-08-30
GB1095378A (ru) * 1965-06-22
DE1543372A1 (de) * 1966-10-18 1971-04-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung von o-substituierten 3,4-Dioxyphenylalkanolaminen

Also Published As

Publication number Publication date
NL169583B (nl) 1982-03-01
ES395482A1 (es) 1973-12-16
HU162736B (ru) 1973-04-28
YU35868B (en) 1981-08-31
PL81424B1 (ru) 1975-08-30
DE1962497C3 (de) 1979-09-20
JPS5116420B1 (ru) 1976-05-24
AT299924B (de) 1972-07-10
NO131126C (ru) 1975-04-09
PL84354B1 (ru) 1976-03-31
FI53301C (fi) 1978-04-10
IE34807B1 (en) 1975-08-20
NL7018031A (ru) 1971-06-15
YU35753B (en) 1981-06-30
CS151064B2 (ru) 1973-09-17
FR2081347A1 (ru) 1971-12-03
SU505349A3 (ru) 1976-02-28
GB1330188A (en) 1973-09-12
AR198224A1 (es) 1974-06-07
IL35840A0 (en) 1971-02-25
AT317192B (de) 1974-08-12
SU417936A3 (ru) 1974-02-28
FR2081347B1 (ru) 1974-08-30
US3966814A (en) 1976-06-29
YU137878A (en) 1981-02-28
NO131126B (ru) 1974-12-30
BG17956A3 (bg) 1974-03-05
KR780000269B1 (en) 1978-07-24
DE1962497B2 (de) 1979-01-25
DK136526C (ru) 1978-03-28
JPS5138716B1 (ru) 1976-10-23
AT302284B (de) 1972-10-10
CS151062B2 (ru) 1973-09-17
RO61132A (ru) 1976-12-15
RO56808A (ru) 1975-03-15
JPS5221505B1 (ru) 1977-06-10
AR194205A1 (es) 1973-06-29
YU35867B (en) 1981-08-31
ES395481A1 (es) 1973-12-16
PL84355B1 (ru) 1976-03-31
KR780000007B1 (en) 1978-03-04
IL35840A (en) 1974-06-30
DE1962497A1 (de) 1971-06-16
YU137978A (en) 1981-02-28
FI53301B (ru) 1977-12-30
RO61063A (fr) 1978-07-15
CH556322A (de) 1974-11-29
CS151063B2 (ru) 1973-09-17
SE378101B (ru) 1975-08-18
NL169583C (nl) 1982-08-02
BE760252A (fr) 1971-06-11
SU384229A3 (ru) 1973-05-23
IE34807L (en) 1971-06-12
YU301070A (en) 1980-12-31
ES386345A1 (es) 1974-01-01

Similar Documents

Publication Publication Date Title
DK134984B (da) Analogifremgangsmåde til fremstilling af alfa-alkylaminopropiophenoner eller syreadditionssalte heraf.
DK124884B (da) Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf.
DK129446B (da) Analogifremgangsmåde til fremstilling af fenoxyhydroxypropylaminer eller syreadditionssalte heraf.
DK127556B (da) Analogifremgangsmåde til fremstilling af quinazolinderivater eller syreadditionssalte deraf.
DK139717B (da) Analogifremgangsmåde til fremstilling af beta-aryl-2-aminoalkoxystyroler eller syreadditionssalte heraf.
DK129581B (da) Analogifremgangsmåde til fremstilling af substituerede N-allyl-2-arylamino-imidazolin-(2)-forbindelser eller syreadditionssalte deraf.
DK135278B (da) Analogifremgangsmåde til fremstilling af fenoksyisopropanolaminderivater eller syreadditionssalte deraf.
DK136526B (da) Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf.
DK130410B (da) Fremgangsmåde til fremstilling af substituerede N-aminoalkyl-arylaminoimidazolin-(2)-forbindelser eller syreadditionssalte deraf.
DK129577B (da) Analogifremgangsmåde til fremstilling af phenacetylguanidiner eller syreadditionssalte deraf.
DK127644B (da) Analogifremgangsmåde til fremstilling af ergopeptiner eller syreadditionssalte deraf.
DK125245B (da) Fremgangsmåde til fremstilling af γpiperidinobutyrophenonderivater eller syreadditionssalte deraf.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK138015B (da) Fremgangsmåde til fremstilling af substituerede N-cycloalkyl-arylamino-imidazoliner-(2) eller syreadditionssalte deraf.
DK120155B (da) Analogifremgangsmåde til fremstilling af aminopropiofenoner eller syreadditionssalte deraf.
DK126327B (da) Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf.
DK129454B (da) Analogifremgangsmåde til fremstilling af ergonorcornin eller syreadditionssalte deraf.
DK136151B (da) Analogifremgangsmåde til fremstilling af basisk substituerede tertiære butanoler eller syreadditionssalte deraf.
DK127424B (da) Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf.
DK129164B (da) Analogifremgangsmåde til fremstilling af 3-alkyl-5-aryloxymethylisoxazoler eller syreadditionssalte deraf.
DK131727B (da) Analogifremgangsmåde til fremstilling af oxazinobenzoxaziner eller syreadditionssalte deraf.
DK127642B (da) Analogifremgangsmåde til fremstilling af benzodioxanderivater eller syreadditionssalte deraf.
DK131147B (da) Fremgangsmåde til fremstilling af butyrophenonderivater eller syreadditionssalte deraf.
DK134023B (da) Analogifremgangsmåde til fremstilling af acyloxypiperazinylforbindelser eller syreadditionssalte deraf.
DK124028B (da) Analogifremgangsmåde til fremstilling af quinolylformiminoethere eller syreadditionssalte deraf.

Legal Events

Date Code Title Description
PBP Patent lapsed